Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced seven upcoming poster presentations at the 2025 American Society of ...

A study from the ORIGINS cohort in Western Australia assessed the diets of one-year-old children, comparing intake to ...

Detailed price information for Cellectar Biosc (CLRB-Q) from The Globe and Mail including charting and trades.

Hedge your bets and cover your nutritional bases with the best multivitamin of 2025, tested and reviewed by a registered ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

The typical end-user price for a Cyclone ® IKON solution is between EUR 10 and 15 million, depending on options and ...

Second Oral Ritual Reverses Bleeding Gums, Strengthens Teeth, and Restores Dental Health Naturally-Backed by Scienc ...

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Despite growing interest in his products, he acknowledged several challenges, including fluctuating global market conditions, ...

Q1 2025 Earnings Call Transcript May 5, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is $1.81, ...